TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer
Jae Kyung Myung, Byung Kuk Kwak, Jung Ah Lim, Myung-Chul Lee, Min Joo Kim
Cancer Res Treat. 2016;48(3):942-947. Published online 2015 Dec 28 DOI: https://doi.org/10.4143/crt.2015.362
Citations to this article as recorded by 
TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
Xilin Nie, Jinbiao Shang, Wendong Wang
Frontiers in Surgery.2023;[Epub] CrossRef
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review
Jingxin Mao, Xingliang Huang, Mohammad K. Okla, Mostafa A. Abdel-Maksoud, Ayman Mubarak, Zahid Hameed, Razia Noreen, Aqsa Chaudhary, Shakira Ghazanfar, Yixuan Liao, Yasir Hameed, Chen Li, Min Tang
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
Emerging mechanisms of telomerase reactivation in cancer
Shalu Sharma, Shantanu Chowdhury
Trends in Cancer.2022; 8(8): 632. CrossRef
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel, Paula Soares
Cancers.2021; 13(9): 2048. CrossRef
Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter
Hui Shi, Le-Hang Guo, Yi-Feng Zhang, Hui-Jun Fu, Jia-Yi Zheng, Han-Xiang Wang, Chong-Ke Zhao, Hui-Xiong Xu
Endocrine.2020; 68(2): 349. CrossRef
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang, Yanping Gong, Shuping Yan, Hui Chen, Siqin Qin, Rixiang Gong
Endocrine.2020; 67(1): 44. CrossRef
Telomerase and CD4 T Cell Immunity in Cancer
Magalie Dosset, Andrea Castro, Hannah Carter, Maurizio Zanetti
Cancers.2020; 12(6): 1687. CrossRef
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre
Genes.2018; 9(5): 241. CrossRef
The clinical significance of PINX1 expression in papillary thyroid carcinoma
JiHoon Kang, Kanghee Han, Hyeon Jin Kim, Ju Hui Park, Jun Suk Kong, Sunhoo Park, Jae Kyung Myung
Human Pathology.2018; 81: 176. CrossRef
The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
Anqi Jin, Jianhao Xu, Yan Wang
Medicine.2018; 97(29): e11548. CrossRef
Prognostic indicators for papillary thyroid carcinoma
Fabio Maino, Raffaella Forleo, Furio Pacini
Expert Review of Endocrinology & Metabolism.2017; 12(2): 101. CrossRef
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu, Xiaotian Yuan, Dawei Xu
Genes.2016; 7(7): 38. CrossRef
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Ramlee, Jing Wang, Wei Toh, Shang Li
Genes.2016; 7(8): 50. CrossRef